drug · small molecule
patient view →roflumilast
pre_registrationupdated 2mo agoby $ARQT Arcutis Biotherapeutics, Inc.🔗 ChEMBL
community read0 votes
Small molecule drug with a maximum clinical stage of Approval (across all indications), with 5 approved and 20 investigational indications.
targets
Phosphodiesterase 4
all catalysts(0)
nothing on the calendar yet
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that